MARKET

ATHX

ATHX

Athersys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.430
-0.010
-0.69%
After Hours: 1.450 +0.02 +1.40% 16:07 09/23 EDT
OPEN
1.420
PREV CLOSE
1.440
HIGH
1.490
LOW
1.400
VOLUME
1.11M
TURNOVER
--
52 WEEK HIGH
2.230
52 WEEK LOW
1.200
MARKET CAP
218.33M
P/E (TTM)
-4.7210
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATHX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ATHX News

  • Athersys, Inc. (NASDAQ:ATHX): Is It Growing Too Fast?
  • Simply Wall St..4d ago
  • Edited Transcript of ATHX earnings conference call or presentation 7-Aug-19 8:30pm GMT
  • Thomson Reuters StreetEvents.09/05 16:22
  • Benzinga's Top Upgrades, Downgrades For August 26, 2019
  • Benzinga.08/26 13:37
  • Dawson James Initiates Coverage On Athersys with Buy Rating, Announces $11 Price Target
  • Benzinga.08/26 12:32

More

Industry

Biotechnology & Medical Research
-0.69%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About ATHX

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.
More

Webull offers Athersys, Inc. (ATHX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.